Oliver Plettenburg

Prof. Dr. Oliver Plettenburg is a Director at the Institute for Medicinal Chemistry, Helmholtz Munich, and Professor (W3) for Medicinal Chemistry at Leibniz Universität Hannover. His career spans academia and industry, with key roles at Sanofi-Aventis in diabetes, oncology, and cardiovascular drug discovery.

• Education: Ph.D. in Chemistry (University of Wuppertal, 1997-2000); Postdoctoral Researcher at Scripps Research Institute (2000-2001)

His research focuses on optimizing chemical substances for therapeutic applications, selective drug delivery to target organs, and developing smart systems for disease visualization. He has published extensively in areas like Chemical Biology, Diabetes, and Nanotechnology, emphasizing PEX14-PEX5 inhibitors, antifibrotic therapeutics, and optoacoustic imaging tools.

• Scientific Awards:
  • Special Achievement Award, Sanofi-Aventis (2008)
  • Milestone Award, Aventis (2002)